Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
PiHKAL
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Impact and popularity== Through ''PIHKAL'' (and later ''[[TIHKAL]]''), Shulgin sought to ensure that his discoveries would escape the limits of professional research labs and find their way to the public, a goal consistent with his stated beliefs that [[psychedelic drug]]s can be valuable tools for self-exploration. The [[MDMA]] ("ecstasy") synthesis published in ''PIHKAL'' remains one of the most common [[clandestine chemistry|clandestine]] methods of its manufacture to this day. Many countries have banned the major substances for which this book gives directions for synthesis, such as [[2C-B]], [[2C-T-2]], and [[2C-T-7]]. In 1994, two years after ''PIHKAL'' was published, the [[Drug Enforcement Administration]] (DEA) raided Shulgin's laboratory and requested that he surrender his DEA license. Richard Meyer, spokesman for DEA's San Francisco Field Division, has stated in reference to ''PIHKAL'' "It is our opinion that those books are pretty much cookbooks on how to make illegal drugs. Agents tell me that in clandestine labs that they have raided, they have found copies of those books", suggesting that the publication of ''PIHKAL'' and the termination of Shulgin's license may have been related.<ref name="Dr. Ecstasy">{{cite news | first = Drake |last=Bennett | url = https://www.nytimes.com/2005/01/30/magazine/30ECSTASY.html | title = Dr. Ecstasy | work = New York Times Magazine | date = January 30, 2005}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)